My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 239

    1.

    New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.

    Ceriello A.

    Diabetes Care. 2003 May;26(5):1589-96. Review.PMID: 12716823 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Molecular targets of diabetic vascular complications and potential new drugs.

    Da Ros R, Assaloni R, Ceriello A.

    Curr Drug Targets. 2005 Jun;6(4):503-9. Review.PMID: 16026269 [PubMed - indexed for MEDLINE]Related articles

    3.

    Antioxidant therapy in diabetic complications: what is new?

    Da Ros R, Assaloni R, Ceriello A.

    Curr Vasc Pharmacol. 2004 Oct;2(4):335-41. Review.PMID: 15320813 [PubMed - indexed for MEDLINE]Related articles

    4.

    The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.

    Kiss L, Szabó C.

    Mem Inst Oswaldo Cruz. 2005 Mar;100 Suppl 1:29-37. Epub 2005 Jun 14. Review.PMID: 15962096 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of gliclazide beyond metabolic control.

    Ceriello A.

    Metabolism. 2006 May;55(5 Suppl 1):S10-5.PMID: 16631804 [PubMed - indexed for MEDLINE]Related articles

    6.

    Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.

    Pacher P, Szabó C.

    Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1568-80. Review.PMID: 16356120 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance.

    Da Ros R, Assaloni R, Ceriello A.

    Diabet Med. 2004 Nov;21(11):1249-52. Review.PMID: 15498094 [PubMed - indexed for MEDLINE]Related articles

    8.

    Oxidative stress and diabetes-associated complications.

    Ceriello A.

    Endocr Pract. 2006 Jan-Feb;12 Suppl 1:60-2. Review.PMID: 16627383 [PubMed - indexed for MEDLINE]Related articles

    9.

    Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.

    Szabo C.

    Br J Pharmacol. 2009 Mar;156(5):713-27. Epub 2009 Feb 6. Review.PMID: 19210748 [PubMed - indexed for MEDLINE]Related articles

    10.

    Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.

    Pacher P, Obrosova IG, Mabley JG, Szabó C.

    Curr Med Chem. 2005;12(3):267-75. Review.PMID: 15723618 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation.

    Soriano FG, Virág L, Szabó C.

    J Mol Med. 2001 Aug;79(8):437-48. Review.PMID: 11511974 [PubMed - indexed for MEDLINE]Related articles

    12.

    Oxidative stress in brain ischemia.

    Love S.

    Brain Pathol. 1999 Jan;9(1):119-31. Review.PMID: 9989455 [PubMed - indexed for MEDLINE]Related articles

    13.

    Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes.

    Ceriello A.

    Curr Opin Lipidol. 2006 Oct;17(5):510-8. Review.PMID: 16960499 [PubMed - indexed for MEDLINE]Related articles

    14.

    Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.

    Rolo AP, Palmeira CM.

    Toxicol Appl Pharmacol. 2006 Apr 15;212(2):167-78. Epub 2006 Feb 20. Review.PMID: 16490224 [PubMed - indexed for MEDLINE]Related articles

    15.

    Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction.

    Mabley JG, Soriano FG.

    Curr Vasc Pharmacol. 2005 Jul;3(3):247-52. Review.PMID: 16026321 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hyperglycemia and the pathobiology of diabetic complications.

    Aronson D.

    Adv Cardiol. 2008;45:1-16. Review.PMID: 18230953 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Novel antioxidant therapeutic strategies for cardiovascular dysfunction associated with ageing]

    Radovits T.

    Orv Hetil. 2008 Dec 14;149(50):2377-85. Hungarian. PMID: 19073445 [PubMed - indexed for MEDLINE]Related articles

    18.

    Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.

    Du X, Matsumura T, Edelstein D, Rossetti L, Zsengellér Z, Szabó C, Brownlee M.

    J Clin Invest. 2003 Oct;112(7):1049-57.PMID: 14523042 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice.

    Johansen JS, Harris AK, Rychly DJ, Ergul A.

    Cardiovasc Diabetol. 2005 Apr 29;4(1):5. Review.PMID: 15862133 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Oxidative stress and diabetic vascular complications.

    Giugliano D, Ceriello A, Paolisso G.

    Diabetes Care. 1996 Mar;19(3):257-67. Review.PMID: 8742574 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity